anti- ACAD9 antibody

Este producto es parte de ACAD - Acyl-CoA Dehydrogenase
Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
anti- ACAD9 antibody
category
Primary Antibodies
provider
FineTest
reference
FNab00062
tested applications
ELISA, WB, IHC

Description

Required for mitochondrial complex I assembly(PubMed:20816094, PubMed:24158852). Has a dehydrogenase activity on palmitoyl-CoA(C16:0) and stearoyl-CoA(C18:0). It is three times more active on palmitoyl-CoA than on stearoyl-CoA. However, it does not play a primary role in long-chain fatty acid oxidation in vivo(PubMed:20816094, PubMed:24158852). Has little activity on octanoyl-CoA(C8:0), butyryl-CoA(C4:0) or isovaleryl-CoA(5:0).

Documents del producto

Instrucciones
Descargar
Data sheet

Product specifications

Category
Primary Antibodies
Immunogen Target
acyl-Coenzyme A dehydrogenase family, member 9
Host
Rabbit
Reactivity
human,mouse,rat
Recommended Dilution
WB: 1:200-1:2000; IHC: 1:20-1:200
Clonality
polyclonal
Conjugation
Unconjugated
Isotype
IgG
Observed MW
69 kDa
Purity
≥95% as determined by SDS-PAGE
Purification
Immunogen affinity purified
Size 1
100µg
Form
liquid
Tested Applications
ELISA, WB, IHC
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3,-20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
UniProt ID
Q9H845
Gene ID
28976
Alias
MC1DN20,NPD002
Background
Antibody anti-ACAD9
Status
RUO
Note
This product is for research use only.

Descripción

ACAD9 is a mitochondrial enzyme essential for the β-oxidation of long-chain fatty acids and the assembly of mitochondrial respiratory chain complex I. It functions as a dehydrogenase, catalyzing the first step in the oxidation of long-chain acyl-CoA substrates, generating energy and maintaining lipid homeostasis. ACAD9 is also a critical assembly factor for complex I, facilitating the proper formation and function of this key component of the electron transport chain. Its dual role in fatty acid oxidation and complex I assembly makes ACAD9 indispensable for mitochondrial energy metabolism. Mutations in the ACAD9 gene are associated with complex I deficiency, a severe mitochondrial disorder that can lead to cardiomyopathy, encephalopathy, and metabolic crises. The high expression of ACAD9 in energy-demanding tissues such as the heart, liver, and brain reflects its importance in maintaining mitochondrial function and energy production, positioning it as a vital enzyme in cellular metabolism.

Related Products

FNab00062

anti- ACAD9 antibody

Required for mitochondrial complex I assembly(PubMed:20816094, PubMed:24158852). Has a dehydrogenase activity on palmitoyl-CoA(C16:0) and stearoyl-CoA(C18:0). It is three times more active on palmitoyl-CoA than on stearoyl-CoA. However, it does not play a primary role in long-chain fatty acid oxidation in vivo(PubMed:20816094, PubMed:24158852). Has little activity on octanoyl-CoA(C8:0), butyryl-CoA(C4:0) or isovaleryl-CoA(5:0).

Ver Producto
P9112

Recombinant Human ACAD9

Ver Producto
P9351

Recombinant Human ACAD9

Ver Producto